![Alyssa Galaro](https://aaadv.org/wp-content/uploads/2020/02/AlyssaGalaro-headshot-scaled-e1686677883777.jpg)
Alyssa Galaro, PhD
Preclinical Cell and Gene Therapy Reviewer FDA
Dr. Galaro joined the Office of Tissues and Advanced Therapies at FDA/CBER in 2018 as a Pharmacology and Toxicology Reviewer. Prior to joining CBER, she worked as a Study Director at a contract research organization and completed her PhD in biomedical engineering at the Johns Hopkins School of Medicine.